newsfilter
← Latest News
Business Wire·

Gilead Sciences Announces Third Quarter 2026 Financial Results

Product Sales Excluding Veklury Increased 16% Year-Over-Year to $8.2 Billion Biktarvy Sales Increased 10% Year-Over-Year to $4.1 Billion Gilead Sciences, Inc. (NASDAQ:GILD) announced today its results of operations